• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameDEXCOM G4 PLATINUM PROFESSIONAL CONTINUOUS GLUCOSE MONITORING SYSTEM
Classification Namesensor, glucose, invasive
ApplicantDEXCOM, INC.
PMA NumberP120005
Supplement NumberS011
Date Received09/16/2013
Decision Date06/03/2014
Product Code
MDS[ Registered Establishments with MDS ]
Advisory Committee Clinical Chemistry
Supplement Typenormal 180 day track
Supplement Reason labeling change - indications
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the g4 platinum professional continuous glucose monitoring system, that includes the dexcom g4 platinum professional receiver shield, to allow multiple patient use of the system by a healthcare professional. The device, as modified, will be marketed under the trade name g4 platinum professional continuous glucose monitoring system and is indicated for: the dexcom g4 platinum professional continuous glucose monitoring system is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. The system is intended for multiple patient use and requires purchase by a healthcare provider. The system is not intended for use in a hospital setting. The dexcom g4 platinum professional system is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home glucose monitoring devices. The dexcom g4 platinum professional system aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments, which may minimize these excursions. Interpretation of the g4 platinum professional system results should be based on the trends and patterns seen with several sequential readings over time.
-
-